Pharmaceutical formulation comprising a low molecular weight thrombin inhibitor and its prodrug
US6962905B1 · kind B1 · utility
Assignee
Inventor
Key dates
| Filing date | Apr 19, 2000 |
| Grant date | Nov 8, 2005 |
| Priority date | — |
| Expiry date | Apr 19, 2020 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P43/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A kit of parts containing (a) a pharmaceutical formulation including a low molecular weight thrombin inhibitor, or a pharmaceutically acceptable derivative thereof, in admixture with a pharmaceutically acceptable adjuvant, diluent or carrier, and (b) a pharmaceutical formulation including a prodrug of a low molecular weight thrombin inhibitor, or a pharmaceutically acceptable derivative of that prodrug, in admixture with a pharmaceutically acceptable adjuvant, diluent or carrier. Components (a) and (b) are each provided in a form that is suitable for administration in conjunction with the other. The kit is useful in the treatment of conditions in which inhibition of thrombin is required or desired.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.